SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-008647
Filing Date
2019-02-15
Accepted
2019-02-15 15:01:02
Documents
4
Period of Report
2019-02-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv513257_8k.htm 8-K 20160
2 EXHIBIT 99.1 tv513257_ex99-1.htm EX-99.1 8479
3 EXHIBIT 99.2 tv513257_ex99-2.htm EX-99.2 372814
4 GRAPHIC image_001.jpg GRAPHIC 15564
  Complete submission text file 0001144204-19-008647.txt   424302
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 19611163
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences